Asthma
AsthmaA multicentre, randomized, open-label, cross-over equivalence study to compare the pharmacodynamic properties, safety, and tolerability of a new combination dry powder of fluticasone propionate and salmeterol (ComboFS) twice daily and the reference product Seretide® Diskus® in patients with asthma.
Asthma – more information:
If you are 18-70 years old and suffer from asthma, please contact our Clinical Research Department.
For your participation in the study, you receive:
- -free care of the best specialists in the field of laryngology and allergology,
- -free medicine with unique effects,
- -follow-up visits with a specialist during the test (16 weeks) during which spirometry, ECG, laboratory tests and basic vital signs will be performed
- -refund of travel costs.
Start of study recruitment: June 2020
Sponsor
The Pharmaceutical Company LEK-AM Sp. z o. o.
